06 / COMMON CJC-1295 QUESTIONS
What are the plain answers about CJC-1295?
Only a few studies exist. Safety isn't settled. The long DAC form and short no-DAC form stay for very different times.
What is CJC-1295, and how does it work?
The short answer is that the drug copies the body's note to the growth gland. Published studies mainly measured hormones in blood. They didn't prove that anyone became healthier.
What is CJC-1295 made from?
CJC-1295 is a peptide, or short chain of protein parts. Four altered spots make the chain harder for the body to break apart [2]. DAC adds a joining part. No-DAC keeps the altered spots but lacks that joining part.
What does CJC-1295 do in the body?
CJC-1295 reaches the growth gland, which releases growth hormone. Growth hormone raises IGF-1, a growth-linked blood protein. In one study, average growth hormone was about 46% higher. IGF-1 was about 45% higher after one week [3].
Growth hormone still rose several times each day [3]. Those brief rises kept their usual timing and size. No better-health result was proved. The study only found higher blood levels.
Why does CJC-1295 with DAC remain longer?
DAC names a joining part on the long form. The part binds the chain to albumin, one of the main blood proteins. Half the drug cleared from blood in 5.8-8.1 days [1]. The joined drug is much larger than the free chain [2].
Is DAC the same as no-DAC?
No. CJC-1295 DAC is the form that remains longer. Half cleared in 5.8-8.1 days [1][16]. No-DAC lacks the albumin bond. It clears far sooner.
Is CJC-1295 a steroid?
No. CJC-1295 is a peptide, or short protein chain [2]. It affects the growth gland. A steroid acts by a separate body route.
What does CJC-1295 ipamorelin mean?
The name joins two lab drugs. CJC-1295 copies the normal growth message [13]. Ipamorelin acts like ghrelin, the body's hunger hormone, through another gland route. The pair may release more growth hormone together [14].
Which findings are firm, and which questions stay open?
<a id="evidence"></a>
What did the published people studies find?
The CJC-1295 people studies were small. One 2006 study found that growth hormone and IGF-1 remained raised for days [1]. A separate 2006 study measured the same two hormones [3]. Half the DAC form cleared in 5.8-8.1 days. A 2009 CJC-1295 study found a protein carrying fat and one carrying thyroid hormone fell. A broken-off albumin part and some antibodies rose with IGF-1 [5].
These early studies did not test lasting safety. They showed no proved health gain. A higher blood level cannot show that you feel better. That limit applies to every answer below.
Why did the CJC-1295 Phase 2 study stop?
The maker ended its Phase 2 study in people with HIV-associated belly fat. That phase is an early test involving more people [7]. A patient death is linked with that time in many accounts. Public sources don't show that CJC-1295 caused the death [7].
What followed one CJC-1295 study shot?
Growth hormone and IGF-1 remained raised for days [1][3]. Daily growth-hormone rises kept their normal pattern. The studies did not prove better sleep, strength, or body fat. CJC-1295 isn't approved for people.
Did CJC-1295 with ipamorelin improve health?
Researchers haven't compared the exact CJC-1295/ipamorelin pair with either drug alone or no drug. Tests of related drugs found more growth hormone when both gland routes were used [13]. Ipamorelin follows the route used by the body's hunger hormone [14]. That explains the pairing, but it doesn't prove a health gain.
What is known about safety and side effects?
<a id="side-effects"></a>
Has CJC-1295 been proved safe?
No large or long people study has proved CJC-1295 safe. Growth hormone can alter body fluid and blood sugar. In 2024, the FDA raised concern about an immune response.
Does being a peptide make the drug safe?
No. A peptide is simply a short chain of protein parts. That name proves nothing about safety. Small people studies can't settle risk over many years [3].
Which CJC-1295 side effects raise concern?
Growth hormone tells the kidneys to keep salt and water. Extra fluid may cause swelling or press on a nerve, causing tingling. Growth hormone may also make insulin control blood sugar less well. In 2024, FDA papers said the body might mount an immune response.
Higher IGF-1 also raises a cancer concern. Broad studies linked higher levels of that protein with certain cancers. This page has no cancer-by-cancer count or size of the added risk. Those studies do not prove that CJC-1295 causes cancer.
Cancer studies cannot say what follows one shot of the drug. They only give your doctor a reason for caution. No large CJC-1295 safety study has answered the question. The gap is real.
Does CJC-1295 change testosterone?
CJC-1295 first raises growth hormone, which then raises IGF-1. The drug does not act straight on the sex-hormone system. Studies found no clear rise or fall in testosterone [3]. Online claims add no sound answer.
Does CJC-1295 lower testosterone?
No people study shows a drop. CJC-1295 acts through the growth gland [2]. Testosterone comes from a separate body system. Published CJC-1295 studies don't support claims of lower testosterone.
Is CJC-1295 safer than testosterone treatment?
No study compared the drugs face to face. CJC-1295 isn't approved and has little safety testing. Testosterone treatment is approved and watched with blood tests. The drugs also act through separate body systems.
What do rules and studies say about its use?
<a id="regulatory"></a>
Is CJC-1295 FDA approved?
No. CJC-1295 isn't approved for people anywhere. In 2024, an FDA group refused to place it on a list of bulk ingredients that some pharmacies may make into medicine for one patient. Sports officials also ban CJC-1295 in tested events. The pharmacy rule and sports ban are separate.
What CJC-1295 amounts appeared in people studies?
The studies gave one shot of 30, 60 or 90 ug/kg [1][3]. The amounts rose with each person's body weight. Those are research facts, not advice. This site doesn't give a human dose.
What CJC-1295 DAC amounts appeared in studies?
One people study gave 30 or 60 ug/kg once. IGF-1 remained raised for 9-11 days [1]. That result applies to long-form DAC. It cannot name a safe amount for you.
Was a CJC-1295 and ipamorelin amount proved?
A fixed CJC-1295/ipamorelin plan has not been compared with no drug or either drug alone in people [13]. CJC-1295 follows the body's normal growth-message route [13][14]. Ipamorelin acts like the hunger hormone through a separate gland route. The pairing has no tested amount or proved health gain.
How did researchers prepare CJC-1295?
Lab staff mixed the dry material with water that slowed germ growth. They kept it cold, then gave it by shot [1][2]. Those facts report lab handling. They aren't home or human-use directions.
Where did studies place the CJC-1295 shot?
Most people studies gave the shot just beneath the skin [1]. Earlier tests put the short, unaltered chain into a vein. These are reports of what researchers did. They are not directions for you.